Nicotinic acetylcholine receptors as targets for antidepressants
- 1 July 2002
- journal article
- review article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 7 (6), 525-535
- https://doi.org/10.1038/sj.mp.4001035
Abstract
Molecular Psychiatry publishes work aimed at elucidating biological mechanisms underlying psychiatric disorders and their treatmentKeywords
This publication has 115 references indexed in Scilit:
- Neuronal nicotinic receptor inhibition for treating mood disorders preliminary controlled evidence with mecamylamineDepression and Anxiety, 2002
- Cigarette SmokingJNCI Journal of the National Cancer Institute, 1999
- Activation and inhibition of the human α7 nicotinic acetylcholine receptor by agonistsNeuropharmacology, 1998
- Histological and Behavioral Protection by (−)-Nicotine against Quinolinic Acid-Induced Neurodegeneration in the HippocampusNeurobiology of Learning and Memory, 1998
- Nicotinic receptor stimulation protects neurons against β‐amyloid toxicityAnnals of Neurology, 1997
- Activation and inhibition of rat neuronal nicotinic receptors by ABT‐418British Journal of Pharmacology, 1997
- Central nicotinic receptor blockade inhibits emotionally conditioned pressor responses in ratsCellular and Molecular Life Sciences, 1996
- Functional Modulation of Human "Ganglionic-like" Neuronal Nicotinic Acetylcholine Receptors (nAChRs) by L-Type Calcium-Channel AntagonistsBiochemical and Biophysical Research Communications, 1995
- A cholinergic antagonist, mecamylamine, blocks light-induced Fos immunoreactivity in specific regions of the hamster suprachiasmatic nucleusBrain Research, 1993
- Serotonergic and cholinergic interaction in the regulation of pituitary-adrenal function in ratsCellular and Molecular Life Sciences, 1985